Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company offers prescription pharmaceuticals for cardiovascular, central nervous system, gastrointestinal tract, pain, diabetes, and other therapeutic areas. It also provides non-prescription products for cough, cold, cerebral, peripheral circulation, gastrointestinal tract, metabolism, and other therapeutic areas, as well as analgesics, vitamins, minerals, and vasoprotectives. In addition, the company offers animal health products, including antiparasitics, antimicrobials, and other products. Further, it provides health resort and tourist services. The company was founded in 1954 and is based in Novo Mesto, Slovenia.
Visit company website
5 years, 5 months ago
Krka d.d. is currently in a long term uptrend where the price is trading 9.2% above its 200 day moving average.
Krka d.d.'s total revenue rose by 281.2% to $2B since the same quarter in the previous year.
Its net income has increased by 299.0% to $291M since the same quarter in the previous year.
Finally, its free cash flow grew by 17.2% to $280M since the same quarter in the previous year.
Based on the above factors, Krka d.d. gets an overall score of 4/5.